Press Release on Annual Audited Financial Results (both Standalone and Consolidated)
MANORAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.2 pts less than Nifty Microcap 250 and 12.9 pts less than its Other Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Manorama Industries delivered exceptional FY26 results with revenue surging 76.1% YoY to INR 13,577 million, driven by favorable product mix and higher fractionation capacity utilization. EBITDA grew 92.5% to INR 3,677 million with margins expanding 230 bps to 27.1%, while PAT jumped 108.1% to INR 2,332 million. The company expanded its Solvent Fractionation Plant 2 capacity by 30% to 32,500 TPA and plans INR 460 crore strategic capex over 2-3 years for forward/backward integration and a new facility in Burkina Faso. Q4 performance was impacted by INR 17.05 crore mark-to-market provision on forward contracts due to adverse currency fluctuations, though operating cash flow remained strong at INR 259 crore. The board announced a dividend of INR 0.80 per share.
Strong operational execution with robust revenue and profit growth positions the company well for long-term value creation. The planned capex and capacity expansion should sustain growth momentum, though forex hedging losses in Q4 warrant monitoring.